These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 21658659)

  • 61. Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Estey E; O'Brien SM; Giles FJ; Koller CA; Kornblau S; Keating M; Kantarjian HM
    Leuk Lymphoma; 1998 Nov; 31(5-6):521-31. PubMed ID: 9922042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrent pernicious anemia and myelodysplastic syndrome.
    Drabick JJ; Davis BJ; Byrd JC
    Ann Hematol; 2001 Apr; 80(4):243-5. PubMed ID: 11401093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia--distinct subgroups or two stages of the same disease?
    Voglová J; Chrobák L; Neuwirtová R; Malasková V; Straka L
    Leuk Res; 2001 Jun; 25(6):493-9. PubMed ID: 11337023
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis.
    Feng R; Bhatt VR; Fu K; Pirruccello S; Yuan J
    Cytometry B Clin Cytom; 2018 Nov; 94(6):901-909. PubMed ID: 30334354
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.
    Nösslinger T; Reisner R; Koller E; Grüner H; Tüchler H; Nowotny H; Pittermann E; Pfeilstöcker M
    Blood; 2001 Nov; 98(10):2935-41. PubMed ID: 11698274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes.
    Wall M
    Methods Mol Biol; 2017; 1541():209-222. PubMed ID: 27910026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts.
    Kasprzak A; Assadi C; Nachtkamp K; Rudelius M; Haas R; Giagounidis A; Götze K; Gattermann N; Germing U
    Ann Hematol; 2023 Jan; 102(1):99-106. PubMed ID: 36409328
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.
    Chang KL; O'Donnell MR; Slovak ML; Dagis AC; Arber DA; Niland JC; Forman SJ
    Leukemia; 2002 Apr; 16(4):623-31. PubMed ID: 11960342
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
    Gur HD; Loghavi S; Garcia-Manero G; Routbort M; Kanagal-Shamanna R; Quesada A; Khogeer H; Pierce S; Medeiros LJ; Kantarjian H; Khoury JD
    Am J Surg Pathol; 2018 Jun; 42(6):799-806. PubMed ID: 29596070
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The clinical management of chronic myelomonocytic leukemia.
    Padron E; Komrokji R; List AF
    Clin Adv Hematol Oncol; 2014 Mar; 12(3):172-8. PubMed ID: 24927265
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical features of a new category, myelodysplastic/myeloproliferative diseases, defined by WHO classification].
    Fukuhara T; Kakinoki Y
    Rinsho Byori; 2006 Mar; 54(3):243-9. PubMed ID: 16637572
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Chronic myelomonocytic leukemia evolved from refractory anemia with excess of blasts, associated with karyotypic abnormality and marked monocytosis].
    Kadowaki N; Kamesaki H; Ohno Y; Amano H; Imanaka T; Takahashi Y; Kobashi Y
    Rinsho Ketsueki; 1988 Nov; 29(11):2145-51. PubMed ID: 3070078
    [No Abstract]   [Full Text] [Related]  

  • 74. Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis.
    Birrer A; Jusufi F; Bernimoulin M; Tichelli A; Gratwohl A; Nissen-Druey C; Dirnhofer S; Meyer-Monard S; Stern M
    Eur J Haematol; 2008 Oct; 81(4):267-72. PubMed ID: 18616511
    [TBL] [Abstract][Full Text] [Related]  

  • 75. JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia.
    Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P
    J Clin Pathol; 2009 Sep; 62(9):798-801. PubMed ID: 19734476
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Not all cases of idiopathic thrombocytopenic purpura [correction of pupura] are what they might first seem.
    Mainwaring CJ; Shutt J; James CM
    Clin Lab Haematol; 2002 Aug; 24(4):261-2. PubMed ID: 12181032
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [An analysis of 26 cases of chronic myelomonocytic leukemia].
    Zheng TL; Song KZ; Hou YH
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):342-6, 382. PubMed ID: 2269033
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new approach for diagnosing chronic myelomonocytic leukemia using structural parameters of Sysmex XN
    Schillinger F; Sourdeau E; Boubaya M; Baseggio L; Clauser S; Cornet E; Debord C; Defour JP; Dubois F; Eveillard M; Galoisy AC; Geay MO; Mullier F; Nivaggioni V; Soenen V; Morel P; Garnache-Ottou F; Ronez E; Bardet V; Deconinck E
    Scand J Clin Lab Invest; 2018 May; 78(3):159-164. PubMed ID: 29310473
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.